DRUG NAME: Methotrexate
; higher CNS concentrations noted in patients with recent cranial irradiation and in patients with primary CNS lymphoma due to disruption of the blood-brain barrier volume of distribution 0.4-0.8 L/kg plasma protein binding 50% Metabolism <10%; hepatic and intracellular active metabolite
Download DRUG NAME: Methotrexate
Information
Domain:
Source:
Link to this page:
Documents from same domain
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Related documents
DRUG NAME: Cytarabine
www.bccancer.bc.caPrior CNS disease may also be risk factors. 6. Methods used to decrease the risk of neurotoxicity in these patients include: decreasing the dose, utilizing a once-daily rather than twice-daily schedule, shortening the course of treatment, and modifying the dose based on the CrCl. 6,23,24
Pharmacology - RS
sc19.weebly.comadrenal suppression, CNS effects and behavioral disturbances, increased susceptibility to infections, and teratogenicity. ... A common finding is systemic vasculitis with eosinophilicinfiltration and granuloma formation. Could also be due to unmasking of vasculitis after steroid withdrawal. January 22 Munir Gharaibehm MD, PhD, MHPE 25.
Peripheral Neuropathy: Differential Diagnosis and Management
www.aafp.orgeral neuropathy or of a lesion in the CNS, and whether a single nerve root, multiple nerve roots, or a peripheral nerve plexus ... hereditary disorder, or vasculitis; order ANA, rheumatoid factor ...
標準的神経治療： 中枢神経の血管炎
www.jsnt.gr.jp中枢神経血管炎はCNSに限局して生じる血管炎である．原因不明 のものはprimary CNS vasculitis（PCNSV）と呼ばれているが，こ れまでにisolated angiitis of the CNS やprimary angiitis of the CNSといった名称も使用されている．2012年のChapel Hill Con-
MOH Pocket Manual in Critical Care
www.moh.gov.saCNS INFECTION15 12 STATUS EPILEPTICUS18 13 ... vessels for AVMs, vasculitis, and other arteriopathies. Consider catheter angiography for young patients, patients with lobar hemorrhage, patients without a history of hypertension, and patients without a clear cause of hemorrhage who are surgical candidates.